Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.40
Delayed Data
As of Feb 27
 -0.02 / -0.83%
Today’s Change
2.18
Today|||52-Week Range
6.64
-9.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
AssetsCash48.5M52.0M96.8M68.5M
 
 
 
 
 
Short Term Investment Cash23.0M3.5M44.8M-28.3M
 
 
 
 
 
Cash & Short Term Investments91.5M78.8M112.1M119.3M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.000.00--
 
InventoriesInventories0.000.00------
 
Current AssetsOther Current Assets765.0K1.6M2.3M2.9M
 
 
 
 
 
Current Assets92.2M80.4M114.3M122.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross22.0M21.9M21.9M21.4M
 
 
 
 
 
Depreciation-20.5M-20.4M-20.6M-20.3M
 
 
 
 
 
Other Assets1.4M384.0K358.0K331.0K
 
 
 
 
 
Total Assets95.2M82.2M115.9M123.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable6.6M5.8M5.2M4.4M
 
 
 
 
 
Short Term Debt9.5M9.3M9.2M9.2M
 
 
 
 
 
Accrued Expenses13.0M15.1M15.5M16.5M
 
 
 
 
 
Other Current Liabilities13.0M15.1M15.5M16.5M
 
 
 
 
 
Other Liabilities32.2M32.4M32.7M33.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt13.9M11.6M9.3M7.0M
 
 
 
 
 
Total Liabilities46.1M44.0M41.9M39.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity49.1M38.2M74.0M83.7M
 
 
 
 
 
Total Shareholder Equity49.1M38.2M74.0M83.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding85.2M87.6M101.3M108.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account